Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zander

Showing results (341-350 of 456) with videos related to

Pageof 46
Sort By:
European Journal of Cancer|April 1, 1981
The treatment of advanced testicular carcinoma with high dose chemotherapy and autologous marrow supportG Blijham, G Spitzer, J Litam, et al.
Annals of Hematology|July 25, 2015
Prognostic factors for survival of patients with newly diagnosed chronic GVHD according to NIH criteriaFrancis Ayuk, Ronja Veit, Tatjana Zabelina, et al.
Bone Marrow Transplantation|February 1, 1995
Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantationN Schmitz, P Dreger, A R Zander, et al.
British Journal of Haematology|August 23, 2012
Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced-intensity allograftingEvgeny Klyuchnikov, Ernst Holler, Martin Bornhäuser, et al.
Journal of Pain and Symptom Management|June 19, 2015
A Quantitative Study of Triggered Palliative Care Consultation for Hospitalized Patients With Advanced CancerGabrielle B Rocque, Toby C Campbell, Sara K Johnson, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
High-efficiency retroviral vector-mediated gene transfer into human T lymphocytesZ X Li, U M Schade, B Fehse, et al.
Blood|August 5, 2004
Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myelomaNicolaus Kröger, Avichai Shimoni, Maria Zagrivnaja, et al.
Bone Marrow Transplantation|March 2, 2011
Circulating CD34(+) cells as prognostic and follow-up marker in patients with myelofibrosis undergoing allo-SCTH Alchalby, M Lioznov, U Fritzsche-Friedland, et al.
Stem Cells and Development|February 11, 2010
Limited immune-modulating activity of porcine mesenchymal stromal cells abolishes their protective efficacy in acute kidney injuryBärbel Brunswig-Spickenheier, Janna Boche, Christof Westenfelder, et al.
Experimental Hematology|January 1, 1985
Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitroJ A Ajani, A A Blaauw, G Spitzer, et al.
Pageof 46

Showing results (341-350 of 456) with videos related to

Sort By:
Pageof 46
European Journal of Cancer|April 1, 1981
The treatment of advanced testicular carcinoma with high dose chemotherapy and autologous marrow supportG Blijham, G Spitzer, J Litam, et al.
Annals of Hematology|July 25, 2015
Prognostic factors for survival of patients with newly diagnosed chronic GVHD according to NIH criteriaFrancis Ayuk, Ronja Veit, Tatjana Zabelina, et al.
Bone Marrow Transplantation|February 1, 1995
Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantationN Schmitz, P Dreger, A R Zander, et al.
British Journal of Haematology|August 23, 2012
Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced-intensity allograftingEvgeny Klyuchnikov, Ernst Holler, Martin Bornhäuser, et al.
Journal of Pain and Symptom Management|June 19, 2015
A Quantitative Study of Triggered Palliative Care Consultation for Hospitalized Patients With Advanced CancerGabrielle B Rocque, Toby C Campbell, Sara K Johnson, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
High-efficiency retroviral vector-mediated gene transfer into human T lymphocytesZ X Li, U M Schade, B Fehse, et al.
Blood|August 5, 2004
Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myelomaNicolaus Kröger, Avichai Shimoni, Maria Zagrivnaja, et al.
Bone Marrow Transplantation|March 2, 2011
Circulating CD34(+) cells as prognostic and follow-up marker in patients with myelofibrosis undergoing allo-SCTH Alchalby, M Lioznov, U Fritzsche-Friedland, et al.
Stem Cells and Development|February 11, 2010
Limited immune-modulating activity of porcine mesenchymal stromal cells abolishes their protective efficacy in acute kidney injuryBärbel Brunswig-Spickenheier, Janna Boche, Christof Westenfelder, et al.
Experimental Hematology|January 1, 1985
Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitroJ A Ajani, A A Blaauw, G Spitzer, et al.
Pageof 46